Quest Enlists Paige’s AI Expertise To Develop Software For Digitized Cancer Diagnosis
Executive Summary
Quest signed an agreement with Paige to develop regulatory-approved software and services to be marketed to expand digital pathology network for pathologists.
You may also be interested in...
Upgraded Paige Suite Gains CE-IVD and UKCA Marks
Paige’s AI has obtained CE-IVD and UKCA marks, allowing the launch of a breakthrough product that can spot biomarkers from images.
Another Set Of Eyes: US FDA Authorizes AI Software To Spot Prostate Cancer
The Paige Prostate is a first-of-its-kind digital prostate imaging analysis software that can act as an extra pair of eyes to help pathologists spot cancer cells.
NeuroMetrix Gets FDA De Novo Authorization For Neuromodulation Device To Treat Fibromyalgia
NeuroMetrix plans to market the prescription-based Quell in the fourth quarter to US rheumatologists and pain medicine physicians.